A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.
With a genome that’s regularly broken into 225,000 pieces and reassembled, a pond protist may be the perfect creature to teach us how genomic stability—often lost in cancer—is maintained.
A new study shows how certain cells ‘cheat’ during cell competition to eliminate their neighbors and take over tissues; the findings could point toward new strategies for treating cancer.
The discovery of genes that control eye growth gives researchers critical information in the search for drugs that can prevent nearsightedness, the world’s most common eye disorder.
Community health workers may be able to help youths with sickle cell disease live healthier lives, according to a new study from Columbia's School of Nursing and Department of Pediatrics.
Insomnia accounts for a significantly greater loss of quality of life at the population level than arthritis, obesity, or depressive disorders, a new study from Columbia Psychiatry has found.
Columbia University awards the 2018 Louisa Gross Horwitz Prize to Pierre Chambon, Ronald M. Evans, and Bert W. O’Malley for their research—spanning over 50 years—decoding how steroid hormones and nuclear receptors regulate cell function.
Columbia University awards the 2018 Horwitz Prize to Pierre Chambon, Ronald Evans, and Bert O’Malley for their research decoding how steroid hormones and nuclear receptors regulate cell function.
A new anti-inflammatory drug may offer hope for people with a progressive form of MS. In a phase 2 trial, the drug slowed brain atrophy in people with the disease.